Introduktion

Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Plew Daniel P Van. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.

Genomsnittlig handelslönsamhet

Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.

Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.

Uppdateringsfrekvens: Dagligen

Se listan över mest lönsamma insiderhandlare

Se högst rankade insiders
Företag med rapporterade insiderpositioner

SEC-anmälningarna visar att Plew Daniel P Van har rapporterat innehav eller affärer i följande företag:

Värdepapper Titel Senaste rapporterade innehav
US:REGN / Regeneron Pharmaceuticals, Inc. EVP & General Mgr, Industrial 34 792
Hur man tolkar diagrammen

Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Plew Daniel P Van. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.

I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.

Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.

Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.

Insiderhandelshistorik

Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Plew Daniel P Van som avslöjats för Securities Exchange Commission (SEC).

Fildatum Transaktionsdatum Schema Ticker Värdepapper Kode 10b5-1 Aktier Återstående aktier Procentuell förandring Aktie
pris		 Transaktionsvärde Återstående
värde
2024-12-18 2024-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −969 34 792 −2,71 730,81 −708 155 25 426 342
2024-12-10 2024-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −492 35 761 −1,36 787,00 −387 204 28 143 907
2024-12-10 2024-12-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 3 499 36 253 10,68
2024-02-16 2024-02-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −200 20 378 −0,97 951,77 −190 354 19 395 169
2024-02-16 2024-02-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −375 20 578 −1,79 950,45 −356 419 19 558 360
2024-02-16 2024-02-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −112 20 953 −0,53 949,07 −106 296 19 885 864
2024-02-16 2024-02-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −150 21 065 −0,71 948,70 −142 305 19 984 366
2024-02-16 2024-02-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −240 21 215 −1,12 947,81 −227 474 20 107 789
2024-02-16 2024-02-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −95 21 455 −0,44 945,81 −89 852 20 292 354
2024-02-16 2024-02-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −620 21 550 −2,80 944,30 −585 466 20 349 665
2024-02-16 2024-02-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −2 691 22 170 −10,82 943,51 −2 538 985 20 917 617
2024-02-16 2024-02-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −275 24 861 −1,09 941,41 −258 888 23 404 394
2024-02-16 2024-02-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −4 261 25 136 −14,49 940,44 −4 007 215 23 638 900
2024-02-16 2024-02-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −750 29 397 −2,49 939,60 −704 700 27 621 421
2024-02-16 2024-02-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −226 30 147 −0,74 938,13 −212 017 28 281 805
2024-02-16 2024-02-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −439 30 373 −1,42 937,94 −411 756 28 488 052
2024-02-13 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −16 341 30 812 −34,66 951,68 −15 551 403 29 323 164
2024-02-13 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 23 125 47 153 96,24 381,40 8 819 875 17 984 154
2024-02-13 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −8 600 24 028 −26,36 951,68 −8 184 448 22 866 967
2024-02-13 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 12 250 32 628 60,11 372,46 4 562 635 12 152 625
2023-12-12 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −669 20 378 −3,18 844,09 −564 696 17 200 866
2023-12-12 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −2 552 21 047 −10,81 844,09 −2 154 118 17 765 562
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 3 199 23 599 15,68
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −1 108 20 400 −5,15 843,79 −934 919 17 213 316
2023-08-25 2023-08-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −2 534 21 508 −10,54 844,27 −2 139 380 18 158 559
2023-08-25 2023-08-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −759 24 042 −3,06 843,31 −640 072 20 274 859
2023-08-25 2023-08-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −617 24 801 −2,43 842,66 −519 921 20 898 811
2023-08-25 2023-08-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −363 25 418 −1,41 841,15 −305 337 21 380 351
2023-08-25 2023-08-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −46 25 781 −0,18 840,74 −38 674 21 675 118
2023-08-25 2023-08-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −148 25 827 −0,57 839,28 −124 213 21 676 085
2023-08-25 2023-08-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −667 25 975 −2,50 838,37 −559 193 21 776 661
2023-08-25 2023-08-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −300 26 642 −1,11 837,53 −251 259 22 313 474
2023-08-25 2023-08-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −625 26 942 −2,27 836,32 −522 700 22 532 133
2023-08-25 2023-08-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −138 27 567 −0,50 835,67 −115 322 23 036 915
2023-08-25 2023-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −16 928 27 705 −37,93 842,66 −14 264 548 23 345 895
2023-08-25 2023-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 23 125 44 633 107,52 381,40 8 819 875 17 023 026
2022-12-20 2022-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 3 798 33 884 12,62
2022-12-13 2022-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −492 30 086 −1,61 753,28 −370 614 22 663 182
2022-11-25 2022-11-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 30 578 0,00 748,17 −748 22 877 542
2022-11-25 2022-11-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −629 30 579 −2,02 747,28 −470 039 22 851 075
2022-11-25 2022-11-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 164 31 208 −3,60 746,42 −868 833 23 294 275
2022-11-25 2022-11-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −256 32 372 −0,78 745,56 −190 863 24 135 268
2022-11-25 2022-11-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −780 32 628 −2,33 744,56 −580 757 24 293 504
2022-11-25 2022-11-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −101 33 408 −0,30 743,66 −75 110 24 844 193
2022-11-25 2022-11-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −99 33 509 −0,29 742,58 −73 515 24 883 113
2022-11-25 2022-11-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 002 33 608 −2,90 741,34 −742 823 24 914 955
2022-11-25 2022-11-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 808 34 610 −4,96 740,29 −1 338 444 25 621 437
2022-11-25 2022-11-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −3 124 36 418 −7,90 739,48 −2 310 136 26 930 383
2022-11-25 2022-11-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −944 39 542 −2,33 738,57 −697 210 29 204 535
2022-11-25 2022-11-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −373 40 486 −0,91 737,37 −275 039 29 853 162
2022-11-25 2022-11-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 005 40 859 −2,40 736,46 −740 142 30 091 019
2022-11-25 2022-11-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −686 41 864 −1,61 735,57 −504 601 30 793 902
2022-11-25 2022-11-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −38 028 42 550 −47,19 741,81 −28 209 551 31 564 016
2022-11-25 2022-11-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 50 000 80 578 163,52 378,98 18 949 000 30 537 450
2022-11-08 2022-11-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −404 30 578 −1,30 747,20 −301 869 22 847 882
2022-11-08 2022-11-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −2 782 30 982 −8,24 746,56 −2 076 930 23 129 922
2022-11-08 2022-11-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 468 33 764 −4,17 745,51 −1 094 409 25 171 400
2022-11-08 2022-11-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −2 032 35 232 −5,45 744,61 −1 513 048 26 234 100
2022-11-08 2022-11-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 100 37 264 −2,87 743,39 −817 729 27 701 685
2022-11-08 2022-11-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −100 38 364 −0,26 742,79 −74 279 28 496 396
2022-11-08 2022-11-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −26 114 38 464 −40,44 725,84 −18 954 586 27 918 710
2022-11-08 2022-11-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 34 000 64 578 111,19 381,92 12 985 280 24 663 630
2022-09-13 2022-09-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −79 30 578 −0,26 722,83 −57 104 22 102 696
2022-09-13 2022-09-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −174 30 657 −0,56 721,38 −125 520 22 115 347
2022-09-13 2022-09-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −181 30 831 −0,58 720,41 −130 394 22 210 961
2022-09-13 2022-09-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −159 31 012 −0,51 719,72 −114 435 22 319 957
2022-09-13 2022-09-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −435 31 171 −1,38 718,50 −312 548 22 396 364
2022-09-13 2022-09-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −647 31 606 −2,01 717,59 −464 281 22 680 150
2022-09-13 2022-09-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 052 32 253 −3,16 716,28 −753 527 23 102 179
2022-09-13 2022-09-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −861 33 305 −2,52 715,39 −615 951 23 826 064
2022-09-13 2022-09-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −267 34 166 −0,78 714,42 −190 750 24 408 874
2022-09-13 2022-09-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −572 34 433 −1,63 713,67 −408 219 24 573 799
2022-09-13 2022-09-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −110 35 005 −0,31 712,44 −78 368 24 938 962
2022-09-13 2022-09-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −70 35 115 −0,20 711,85 −49 830 24 996 613
2022-09-13 2022-09-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 35 185 −0,01 710,25 −1 420 24 990 146
2022-09-13 2022-09-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −87 35 187 −0,25 709,93 −61 764 24 980 307
2022-09-13 2022-09-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −35 304 35 274 −50,02 730,96 −25 805 812 25 783 883
2022-09-13 2022-09-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 40 000 70 578 130,81 555,67 22 226 800 39 218 077
2022-02-24 2022-02-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 015 30 578 −3,21 618,16 −627 432 18 902 096
2022-02-24 2022-02-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 176 31 593 −3,59 617,48 −726 156 19 508 046
2022-02-24 2022-02-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −734 32 769 −2,19 616,40 −452 438 20 198 812
2022-02-24 2022-02-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −300 33 503 −0,89 615,20 −184 560 20 611 046
2022-02-24 2022-02-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −600 33 803 −1,74 614,53 −368 718 20 772 958
2022-02-24 2022-02-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −600 34 403 −1,71 612,44 −367 464 21 069 773
2022-02-24 2022-02-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −800 35 003 −2,23 611,65 −489 320 21 409 585
2022-02-24 2022-02-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −200 35 803 −0,56 610,41 −122 082 21 854 509
2022-02-24 2022-02-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −400 36 003 −1,10 609,62 −243 848 21 948 149
2022-02-24 2022-02-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −800 36 403 −2,15 608,29 −486 632 22 143 581
2022-02-24 2022-02-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −156 37 203 −0,42 607,94 −94 839 22 617 192
2022-02-24 2022-02-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −40 000 0 −100,00
2022-02-24 2022-02-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −33 219 37 359 −47,07 610,56 −20 282 193 22 809 911
2022-02-24 2022-02-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 40 000 70 578 130,81 399,66 15 986 400 28 207 203
2021-12-14 2021-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −697 30 578 −2,23 664,34 −463 045 20 314 189
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		A - Award 18 548 18 548
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 4 344 31 275 16,13
2021-11-17 2021-11-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −500 26 931 −1,82 660,51 −330 255 17 788 195
2021-11-17 2021-11-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −2 403 27 431 −8,05 659,42 −1 584 586 18 088 550
2021-11-17 2021-11-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −697 29 834 −2,28 658,50 −458 974 19 645 689
2021-11-17 2021-11-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −200 30 531 −0,65 657,18 −131 436 20 064 363
2021-11-17 2021-11-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −350 30 731 −1,13 655,03 −229 260 20 129 727
2021-11-17 2021-11-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 260 31 081 −3,90 654,33 −824 456 20 337 231
2021-11-17 2021-11-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −840 32 341 −2,53 653,41 −548 864 21 131 933
2021-11-17 2021-11-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −528 33 181 −1,57 652,20 −344 362 21 640 648
2021-11-17 2021-11-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −25 000 0 −100,00
2021-11-17 2021-11-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −18 222 33 709 −35,09 641,50 −11 689 413 21 624 324
2021-11-17 2021-11-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 25 000 51 931 92,83 270,43 6 760 750 14 043 700
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −300 26 931 −1,10 616,27 −184 881 16 596 767
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −280 27 231 −1,02 615,22 −172 262 16 753 056
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 120 27 511 −3,91 614,33 −688 050 16 900 833
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 600 28 631 −5,29 613,34 −981 344 17 560 538
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −900 30 231 −2,89 612,45 −551 205 18 514 976
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −400 31 131 −1,27 611,57 −244 628 19 038 786
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −100 31 531 −0,32 610,81 −61 081 19 259 450
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −200 31 631 −0,63 609,25 −121 850 19 271 187
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −697 31 831 −2,14 608,50 −424 124 19 369 164
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −762 32 528 −2,29 607,21 −462 694 19 751 327
2021-08-10 2021-08-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −244 33 290 −0,73 606,50 −147 986 20 190 385
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −25 000 25 000 −50,00
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −18 397 33 534 −35,43 617,68 −11 363 459 20 713 281
2021-08-10 2021-08-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 25 000 51 931 92,83 270,43 6 760 750 14 043 700
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		A - Award 19 950 19 950
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 5 000 26 931 22,80
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 1 930 21 931 9,65
2020-08-27 2020-08-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 288 20 001 −6,05 614,24 −791 141 12 285 414
2020-08-27 2020-08-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 560 21 289 −6,83 613,62 −957 247 13 063 356
2020-08-27 2020-08-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −4 044 22 849 −15,04 612,49 −2 476 910 13 994 784
2020-08-27 2020-08-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 980 26 893 −6,86 611,40 −1 210 572 16 442 380
2020-08-27 2020-08-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −7 981 28 873 −21,66 610,41 −4 871 682 17 624 368
2020-08-27 2020-08-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −10 256 36 854 −21,77 609,71 −6 253 186 22 470 252
2020-08-24 2020-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −75 000 0 −100,00
2020-08-24 2020-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −47 891 47 110 −50,41 614,09 −29 409 384 28 929 780
2020-08-24 2020-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 75 000 95 001 374,98 179,13 13 434 750 17 017 529
2020-05-08 2020-05-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −700 28 251 −2,42 569,42 −398 594 16 086 684
2020-05-08 2020-05-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −3 040 28 951 −9,50 568,57 −1 728 453 16 460 670
2020-05-08 2020-05-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −3 753 31 991 −10,50 567,35 −2 129 265 18 150 094
2020-05-08 2020-05-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −7 297 35 744 −16,95 566,47 −4 133 532 20 247 904
2020-05-08 2020-05-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −5 984 43 041 −12,21 565,49 −3 383 892 24 339 255
2020-05-08 2020-05-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −3 000 49 025 −5,77 564,54 −1 693 620 27 676 574
2020-05-08 2020-05-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −2 195 52 025 −4,05 563,58 −1 237 058 29 320 250
2020-05-08 2020-05-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −2 077 54 220 −3,69 562,45 −1 168 209 30 496 039
2020-05-08 2020-05-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −4 988 56 297 −8,14 561,55 −2 801 011 31 613 580
2020-05-08 2020-05-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −3 231 61 285 −5,01 560,53 −1 811 072 34 352 081
2020-05-08 2020-05-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −500 64 516 −0,77 559,20 −279 600 36 077 347
2020-05-08 2020-05-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −2 118 65 016 −3,15 558,43 −1 182 755 36 306 885
2020-05-08 2020-05-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −600 67 134 −0,89 557,59 −334 554 37 433 247
2020-05-08 2020-05-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −100 67 734 −0,15 556,92 −55 692 37 722 419
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −52 500 0 −100,00
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −33 079 52 500 −38,65
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −28 217 67 834 −29,38 555,77 −15 682 162 37 700 102
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 52 500 96 051 120,55 52,03 2 731 575 4 997 534
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −17 779 43 551 −28,99 555,77 −9 881 035 24 204 339
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 33 079 61 330 117,09 52,03 1 721 100 3 191 000
2020-02-27 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −210 28 251 −0,74 460,30 −96 663 13 003 935
2020-02-27 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 425 28 461 −4,77 459,33 −654 545 13 072 991
2020-02-27 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −5 274 29 886 −15,00 458,45 −2 417 865 13 701 237
2020-02-27 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −3 787 35 160 −9,72 457,59 −1 732 893 16 088 864
2020-02-27 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 435 38 947 −3,55 456,50 −655 078 17 779 306
2020-02-27 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 300 40 382 −3,12 455,50 −592 150 18 394 001
2020-02-27 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −711 41 682 −1,68 454,53 −323 171 18 945 719
2020-02-27 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −1 000 42 393 −2,30 453,57 −453 570 19 228 193
2020-02-27 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −300 43 393 −0,69 452,53 −135 759 19 636 634
2020-02-27 2020-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale −200 43 693 −0,46 451,61 −90 322 19 732 196
2020-02-27 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −32 735 0 −100,00
2020-02-27 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −17 093 43 893 −28,03 447,30 −7 645 699 19 633 339
2020-02-27 2020-02-25 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 32 735 60 986 115,87 30,63 1 002 673 1 868 001
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		A - Award 24 500 24 500
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 5 000 28 251 21,50
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		A - Award 2 625 23 251 12,73
2018-12-14 2018-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 46 250 46 250
2017-12-13 2017-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 50 000 50 000
2016-12-19 2016-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 34 000 34 000
2016-05-19 2016-05-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −4 413 1 921 −69,67 385,77 −1 702 403 741 064
2016-05-19 2016-05-17 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −9 460 32 735 −22,42
2016-05-19 2016-05-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −4 301 6 334 −40,44 388,14 −1 669 390 2 458 479
2016-05-19 2016-05-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −746 10 635 −6,55 388,14 −289 552 4 127 869
2016-05-19 2016-05-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 9 460 11 381 492,45 30,63 289 760 348 600
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 40 000 40 000
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −1 921 0 −100,00
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 1 921 1 921 52,03 99 950 99 950
2015-11-10 2015-11-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 223 0 −100,00 557,14 −681 382
2015-11-10 2015-11-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 000 1 223 −44,98 556,00 −556 000 679 988
2015-11-10 2015-11-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −2 000 2 223 −47,36 554,39 −1 108 780 1 232 409
2015-11-10 2015-11-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −50 4 223 −1,17 552,50 −27 625 2 333 208
2015-11-10 2015-11-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −850 4 273 −16,59 551,45 −468 732 2 356 346
2015-11-10 2015-11-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −5 486 42 195 −11,51
2015-11-10 2015-11-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −5 700 47 681 −10,68
2015-11-10 2015-11-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −2 674 5 123 −34,30 559,49 −1 496 076 2 866 267
2015-11-10 2015-11-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −300 7 797 −3,71 559,49 −167 847 4 362 344
2015-11-10 2015-11-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 5 486 8 097 210,11 30,63 168 036 248 011
2015-11-10 2015-11-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −2 778 2 611 −51,55 559,49 −1 554 263 1 460 828
2015-11-10 2015-11-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −311 5 389 −5,46 559,49 −174 001 3 015 092
2015-11-10 2015-11-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 5 700 5 700 30,63 174 591 174 591
2015-08-07 2015-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 128 0 −100,00 586,24 −661 279
2015-08-07 2015-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −900 1 128 −44,38 585,02 −526 518 659 903
2015-08-07 2015-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 000 2 028 −33,03 583,89 −583 890 1 184 129
2015-08-07 2015-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 000 3 028 −24,83 582,12 −582 120 1 762 659
2015-08-07 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −4 605 53 381 −7,94
2015-08-07 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −4 095 0 −100,00
2015-08-07 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −2 035 4 028 −33,56 588,64 −1 197 882 2 371 042
2015-08-07 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −147 6 063 −2,37 588,64 −86 530 3 568 924
2015-08-07 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 4 095 6 210 193,62 21,25 87 019 131 962
2015-08-07 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −2 251 2 115 −51,56 588,64 −1 325 029 1 244 974
2015-08-07 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −239 4 366 −5,19 588,64 −140 685 2 570 002
2015-08-07 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 4 605 4 605 30,63 141 051 141 051
2015-05-26 2015-05-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −99 0 −100,00 510,02 −50 492
2015-05-26 2015-05-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −7 506 99 −98,70 509,34 −3 823 106 50 425
2015-05-26 2015-05-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −3 886 7 605 −33,82 508,53 −1 976 148 3 867 371
2015-05-26 2015-05-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −6 879 11 491 −37,45 507,34 −3 489 992 5 829 844
2015-05-26 2015-05-22 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −26 250 57 986 −31,16
2015-05-26 2015-05-22 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −13 800 4 095 −77,12
2015-05-26 2015-05-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −6 823 18 370 −27,08 516,48 −3 523 943 9 487 738
2015-05-26 2015-05-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −567 25 193 −2,20 516,48 −292 844 13 011 681
2015-05-26 2015-05-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 13 800 25 760 115,38 21,25 293 250 547 400
2015-05-26 2015-05-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −12 734 11 960 −51,57 516,48 −6 576 856 6 177 101
2015-05-26 2015-05-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −1 556 24 694 −5,93 516,48 −803 643 12 753 957
2015-05-26 2015-05-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 26 250 26 250 30,63 804 038 804 038
2015-02-24 2015-02-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −3 331 18 705 −15,12 429,09 −1 429 299 8 026 128
2015-02-24 2015-02-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −2 100 22 036 −8,70 428,27 −899 367 9 437 358
2015-02-24 2015-02-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 700 24 136 −6,58 427,12 −726 104 10 308 968
2015-02-24 2015-02-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −2 300 25 836 −8,17 426,08 −979 984 11 008 203
2015-02-24 2015-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −20 000 17 895 −52,78
2015-02-24 2015-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −9 569 28 136 −25,38 424,70 −4 063 954 11 949 359
2015-02-24 2015-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −1 000 37 705 −2,58 424,70 −424 700 16 013 314
2015-02-24 2015-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 20 000 38 705 106,92 21,25 425 000 822 481
2014-12-19 2014-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −3 264 0 −100,00
2014-12-19 2014-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 3 264 18 705 21,14 30,63 99 976 572 934
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 40 000 40 000
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 52 500 85 579 158,71
2014-11-14 2014-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 501 15 441 −8,86 399,95 −600 325 6 175 628
2014-11-14 2014-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −7 074 16 942 −29,46 399,21 −2 824 012 6 763 416
2014-11-14 2014-11-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −18 700 37 895 −33,04
2014-11-14 2014-11-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −9 129 24 016 −27,54 398,93 −3 641 832 9 580 703
2014-11-14 2014-11-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −996 33 145 −2,92 398,93 −397 334 13 222 535
2014-11-14 2014-11-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 18 700 34 141 121,11 21,25 397 375 725 496
2014-08-07 2014-08-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −6 806 15 441 −30,59 338,37 −2 302 946 5 224 771
2014-08-07 2014-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −15 000 56 595 −20,95
2014-08-07 2014-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −7 246 22 247 −24,57 336,11 −2 435 453 7 477 439
2014-08-07 2014-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −948 29 493 −3,11 336,11 −318 632 9 912 892
2014-08-07 2014-08-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 15 000 30 441 97,14 21,25 318 750 646 871
2014-05-23 2014-05-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −2 369 15 441 −13,30 296,70 −702 882 4 581 345
2014-05-23 2014-05-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −3 000 17 810 −14,42 295,33 −885 990 5 259 827
2014-05-23 2014-05-22 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −11 200 71 595 −13,53
2014-05-23 2014-05-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −5 028 20 810 −19,46 296,19 −1 489 243 6 163 714
2014-05-23 2014-05-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −803 25 838 −3,01 296,19 −237 841 7 652 957
2014-05-23 2014-05-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 11 200 26 641 72,53 21,25 238 000 566 121
2013-12-19 2013-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −4 705 0 −100,00
2013-12-19 2013-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 4 705 15 441 43,82 21,25 99 981 328 121
2013-12-17 2013-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 50 000 50 000
2013-12-17 2013-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 52 500 84 236 165,43
2013-09-19 2013-09-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 000 10 736 −8,52 308,26 −308 260 3 309 479
2013-09-19 2013-09-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −3 200 11 736 −21,42 307,28 −983 296 3 606 238
2013-09-19 2013-09-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −3 600 14 936 −19,42 306,40 −1 103 040 4 576 390
2013-09-19 2013-09-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −3 556 18 536 −16,10 305,14 −1 085 078 5 656 075
2013-09-19 2013-09-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 444 22 092 −6,14 304,16 −439 207 6 719 503
2013-09-19 2013-09-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −600 23 536 −2,49 303,01 −181 806 7 131 643
2013-09-19 2013-09-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 400 24 136 −5,48 301,42 −421 988 7 275 073
2013-09-19 2013-09-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −2 600 25 536 −9,24 300,62 −781 612 7 676 632
2013-09-19 2013-09-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −2 800 28 136 −9,05 299,34 −838 152 8 422 230
2013-09-19 2013-09-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −3 777 30 936 −10,88 298,28 −1 126 604 9 227 590
2013-09-19 2013-09-17 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −52 500 0 −100,00
2013-09-19 2013-09-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −25 531 34 713 −42,38 294,75 −7 525 262 10 231 657
2013-09-19 2013-09-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −2 992 60 244 −4,73 294,75 −881 892 17 756 919
2013-09-19 2013-09-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 52 500 63 236 489,01 16,80 882 000 1 062 365
2013-05-08 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −2 037 10 736 −15,95 262,15 −534 000 2 814 442
2013-05-08 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −10 988 12 773 −46,24 261,56 −2 874 021 3 340 906
2013-05-08 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −700 23 761 −2,86 260,88 −182 616 6 198 770
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −29 048 52 500 −35,62
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −3 902 0 −100,00
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −13 450 24 461 −35,48 260,44 −3 502 918 6 370 623
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −1 873 37 911 −4,71 260,44 −487 804 9 873 541
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 29 048 39 784 270,57 16,80 488 006 668 371
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 3 902 10 736 57,10 16,80 65 554 180 365
2012-12-21 2012-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −2 050 3 902 −34,44
2012-12-21 2012-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 2 050 6 834 42,85 16,80 34 440 114 811
2012-12-18 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 75 000 75 000
2012-12-18 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 52 500 82 795 173,30
2012-11-16 2012-11-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −4 384 4 784 −47,82 157,44 −690 217 753 193
2012-11-16 2012-11-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −400 9 168 −4,18 156,94 −62 776 1 438 826
2012-11-16 2012-11-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −2 000 9 568 −17,29 156,17 −312 340 1 494 235
2012-11-16 2012-11-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −6 900 11 568 −37,36 155,18 −1 070 742 1 795 122
2012-11-16 2012-11-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −4 400 18 468 −19,24 154,77 −680 988 2 858 292
2012-11-16 2012-11-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −657 22 868 −2,79 153,48 −100 836 3 509 781
2012-10-26 2012-10-25 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −30 000 0 −100,00
2012-10-26 2012-10-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −11 922 23 525 −33,63 159,55 −1 902 155 3 753 414
2012-10-26 2012-10-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −4 121 35 447 −10,41 159,55 −657 506 5 655 569
2012-10-26 2012-10-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 30 000 39 568 313,55 21,92 657 600 867 331
2012-04-30 2012-04-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −13 143 9 568 −57,87 136,42 −1 792 968 1 305 267
2012-04-30 2012-04-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −1 299 22 711 −5,41 135,94 −176 586 3 087 333
2012-04-30 2012-04-27 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −30 432 0 −100,00
2012-04-30 2012-04-27 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −4 784 0 −100,00
2012-04-30 2012-04-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 4 784 24 010 24,88 20,90 99 986 501 809
2012-04-30 2012-04-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −11 394 19 226 −37,21 138,36 −1 576 474 2 660 109
2012-04-30 2012-04-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −4 596 30 620 −13,05 138,36 −635 903 4 236 583
2012-04-30 2012-04-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 30 432 35 216 636,12 20,90 636 029 736 014
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)